Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sugantha Priya Elayapillai
Observed names:
Sugantha Elayapillai,
Sugantha P. Elayapillai,
Sugantha Priya-Elayapillai,
Suganthapriya Elayapillai
Institutions:
OU Health Stephenson Cancer Center,
University of Oklahoma Health Sciences Center,
University of Oklahoma
Observed institutions:
University of Madras,
OU Health Stephenson Cancer Center,
University of Oklahoma Health Sciences Center,
University of Oklahoma
ORCID:
0000-0001-5596-7663
Observed ORCID:
0000-0001-5596-7663
OpenAlex ID:
A5020406504
Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1 cell line
2019
·
Dhanaraj Teekaraman
, Sugantha Priya Elayapillai
, et al.
·
Chemico-Biological Interactions
·
129
Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer
2020
·
Suganthapriya Elayapillai
, Satishkumar Ramraj
, et al.
·
Gynecologic Oncology
·
57
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53
2019
·
Satish K. Ramraj
, Sugantha P. Elayapillai
, et al.
·
International Journal of Cancer
·
43
Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer
2023
·
Samrita Dogra
, Sugantha Priya Elayapillai
, et al.
·
Cancer Letters
·
18
PDF
Ameliorative effect of α-tocopherol on polychlorinated biphenyl (PCBs) induced testicular Sertoli cell dysfunction in F 1 prepuberal rats
2017
·
Sugantha Priya Elayapillai
, Dhanaraj Teekaraman
, et al.
·
Experimental and Toxicologic Pathology
·
13
ATR inhibition increases reliance on PARP-mediated DNA repair revealing an improved therapeutic strategy for cervical cancer
2024
·
Sugantha Priya Elayapillai
, Samrita Dogra
, et al.
·
Gynecologic Oncology
·
11
PDF
Preferential release of microRNAs via extracellular vesicles is associated with ductal carcinoma in situ to invasive breast cancer progression
2025
·
Sugantha Priya Elayapillai
, Samrita Dogra
, et al.
·
Cancer Letters
·
8
Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer
2024
·
Sugantha Priya Elayapillai
, Anjalika Gandhi
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
4
Spatially Resolved Obesity-Driven Molecular Changes in Early Breast Cancer
2026
·
Cole Hladik
, Malika Sekhri
, et al.
·
American Journal Of Pathology
·
3
Nanoluciferase-CD63 labeling reveals extracellular vesicle kinetics in a mouse intraductal model of ductal carcinoma in situ
2026
·
Cole Hladik
, Sugantha Priya Elayapillai
, et al.
·
Breast Cancer Research
·
2
DCLK1 regulates stemness and IL-6/STAT3–dependent metastatic niche formation in chemoresistant ovarian cancer
2026
·
Samrita Dogra
, Sugantha Priya Elayapillai
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
1
DCLK1 regulates stemness and IL-6/STAT3–dependent metastatic niche formation in chemoresistant ovarian cancer
2026
·
Samrita Dogra
, Sugantha Priya Elayapillai
, et al.
·
Figshare
Characterization of the tumor immune microenvironment in a syngeneic orthotopic mouse model of endometrial carcinoma: a pilot study
2026
·
Nicole Minalt
, Saeede Soleimanian
, et al.
·
Gynecologic Oncology
Elucidating the role of DCLK1 in mediating chemoresistance to platinum and PARP inhibitors in ovarian cancer
2026
·
Bethany Werner
, Samrita Dogra
, et al.
·
Gynecologic Oncology
Corrigendum to “Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer” [Cancer Lett. 2023 Dec 1;578:216437]
2025
·
Samrita Dogra
, Sugantha Priya Elayapillai
, et al.
·
Cancer Letters
Abstract 6647: Targeting DCLK1-mediated glutamine addiction in chemoresistant ovarian cancer
2025
·
Samrita Dogra
, Cole Hladik
, et al.
·
Cancer Research
Doublecortin-like kinase 1 (DCLK1) Promotes Platinum-Resistance and is a Novel Therapeutic Target for Ovarian Cancer
2023
·
Samrita Dogra
, Sugantha Priya Elayapillai
, et al.
·
Cancer Letters
Abstract B012: Exosome microRNAs are progressively altered and contribute to invasive progression of ductal carcinoma in situ
2022
·
Bethany Hannafon
, Samrita Dogra
, et al.
·
Cancer Prevention Research
Abstract 4652: Repurposing mebendazole in combination with PRIMA1MET for ovarian cancer therapy
2019
·
Sugantha Priya Elayapillai
, Satish Kumar Ramraj
, et al.
·
Cancer Research
Abstract LB-244: Prevention of ovarian cancer tumor establishment with mortalin targeting and p53 reactivator drugs
2019
·
Satish Kumar Ramraj
, Zitha Redempta Isingizwe
, et al.
·
Prevention, Early Detection, and Interception
Abstract LB-244: Prevention of ovarian cancer tumor establishment with mortalin targeting and p53 reactivator drugs
2019
·
Satish Kumar Ramraj
, Zitha Redempta Isingizwe
, et al.
·
Cancer Research
Abstract 4652: Repurposing mebendazole in combination with PRIMA1METfor ovarian cancer therapy
2019
·
Sugantha Priya Elayapillai
, Satish Kumar Ramraj
, et al.
·
Tumor Biology
Show more works
View as search
Works count:
24
Citation count:
289
H-index:
7
I10-index:
6
Year
Topic
Type